Literature DB >> 12473275

Systemic sclerosis.

Gabriele Valentini1, Carol Black.   

Abstract

Systemic sclerosis (SSc) presents with a great deal of variability from patient to patient and classification and subset criteria will be analysed and discussed. SSc has been reported in people from all over the world. The prevalence and incidence, however, varies from country to country and within the same country in different ethnic groups. These differences will be elucidated. Genetic and environmental factors associated with the disease will be discussed.SSc is predominantly a female disease, with the female:male ratio ranging from 3:1 to 8:1 and being higher in childbearing years. Progenitor cells acquired during pregnancy have been suggested to play a role by inducing a graft-versus-host disease (microchimerism). Recent epidemiological studies on the relationship between SSc and previous pregnancies will be discussed. SSc is associated with a significant morbidity and mortality. Survival has improved in the last 15 years. Factors associated with such improvement will be analysed.

Entities:  

Mesh:

Year:  2002        PMID: 12473275     DOI: 10.1053/berh.2002.0258

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  11 in total

1.  Association of the interleukin-10 1082G/A, 819C/T and 3575T/A gene polymorphisms with systemic sclerosis: a meta-analysis.

Authors:  Wen-jia Peng; Bing-xiang Wang; Hai-feng Pan; Jin-hui Tao; Jun-qing Zhang; Qian He; Chang-chun Xiao; Jing Wang
Journal:  Mol Biol Rep       Date:  2012-02-04       Impact factor: 2.316

2.  Oropharyngolaryngeal disorders in scleroderma: development and validation of the SLS scale.

Authors:  Chiara Vitali; Elisa Borghi; Arianna Napoletano; Francesca Polini; Monica Caronni; Paola Ammenti; Davide Cattaneo
Journal:  Dysphagia       Date:  2009-08-26       Impact factor: 3.438

3.  Illness Identity in Adults with a Chronic Illness.

Authors:  Leen Oris; Koen Luyckx; Jessica Rassart; Liesbet Goubert; Eva Goossens; Silke Apers; Seher Arat; Joris Vandenberghe; René Westhovens; Philip Moons
Journal:  J Clin Psychol Med Settings       Date:  2018-12

4.  Serum prolidase activity in systemic sclerosis.

Authors:  Ahmet Celik; Muhammed Nur Birer; Metin Kilinc
Journal:  Clin Rheumatol       Date:  2017-05-22       Impact factor: 2.980

Review 5.  Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review and meta-analysis.

Authors:  Xin Feng; Xiao-Qing Li; Zheng Jiang
Journal:  Clin Rheumatol       Date:  2021-01-11       Impact factor: 2.980

6.  Endothelin-1, α-Klotho, 25(OH) Vit D levels and severity of disease in scleroderma patients.

Authors:  Mehrzad Hajialilo; Parisa Noorabadi; Sepideh Tahsini Tekantapeh; Aida Malek Mahdavi
Journal:  Rheumatol Int       Date:  2017-08-22       Impact factor: 2.631

Review 7.  Innate Immunity in Systemic Sclerosis.

Authors:  Christopher Dowson; Nathan Simpson; Laura Duffy; Steven O'Reilly
Journal:  Curr Rheumatol Rep       Date:  2017-01       Impact factor: 4.592

8.  Prevalence of systemic sclerosis in Split-Dalmatia county in Southern Croatia.

Authors:  Mislav Radić; Dusanka Martinović Kaliterna; Damir Fabijanić; Josipa Radić
Journal:  Clin Rheumatol       Date:  2010-04       Impact factor: 2.980

Review 9.  The effect of TGF-β1 polymorphism on systemic sclerosis: a systematic review and pooled analysis of available literature.

Authors:  Ya-nan Wan; Yu-jie Wang; Jun-wei Yan; Xiang-pei Li; Jin-hui Tao; Bing-xiang Wang; Wen-jia Peng; Jing Wang
Journal:  Rheumatol Int       Date:  2013-07-18       Impact factor: 2.631

10.  Endothelin-1 in systemic sclerosis.

Authors:  Mehrdad Aghaei; Farhad Gharibdost; Habib Zayeni; Maryam Akhlaghi; Sima Sedighi; Abduo Rahman Rostamian; Naser Aghdami; Mahdieh Shojaa
Journal:  Indian Dermatol Online J       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.